Tag Archives: SRPT

Hot Casino Stocks For 2019

1. Stock market overview: U.S. stock futures were a bit sluggish Monday after major indexes hit fresh record highs last week.

Asian markets closed with mixed results, and European markets also struggled to find direction.

The Dow Jones industrial average, S&P 500 and Nasdaq all rose by more than 2% over the past week to hit all-time highs.

Before the Bell newsletter: Key market news. In your inbox. Subscribe now!

2. Watching Wynn: Investors are closely monitoring shares in casino firms Wynn Macau (WYNMY) and Wynn Resorts (WYNN).

Shares in Wynn Resorts plunged more than 10% Friday after a Wall Street Journal story detailed numerous allegations of sexual misconduct against founder and CEO Steve Wynn.

Wynn denied the charges in the Journal story.

“The idea that I ever assaulted any woman is preposterous,” he said in a statement that the company sent to CNN.

On Monday, Wynn Macau stock fell 6.5% in Hong Kong.

Hot Casino Stocks For 2019: Liberty TripAdvisor Holdings, Inc.(LTRPA)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Liberty TripAdvisor Holdings, Inc. (NASDAQ: LTRPA) shares jumped 31.6 percent to $12.18 following TripAdvisor Q1 earnings beat.
    ZAGG Inc (NASDAQ: ZAGG) rose 26.5 percent to $14.55 after the company posted better-than-expected Q1 earnings.
    OPKO Health, Inc. (NASDAQ: OPK) shares gained 25 percent to $4.0234 following Q1 beat.
    Axon Enterprise, Inc. (NASDAQ: AAXN) jumped 23.5 percent to $55.12 following a big Q1 beat. The company raised its fiscal 2018 sales growth guidance from 16-18 percent to 18-20 percent.
    Penn Virginia Corporation (NASDAQ: PVAC) gained 23.3 percent to $59.00 after reporting Q1 results.
    TripAdvisor, Inc. (NASDAQ: TRIP) rose 22.5 percent to $47.51 after the company reported stronger-than-expected results for its first quarter on Tuesday.
    Sears Holdings Corporation (NASDAQ: SHLD) shares surged 21.7 percent to $3.36. Amazon.com's partnership with Sears started in 2017 with an agreement to sell Kenmore-branded appliances online. On Wednesday, the companies announced an extension of their relationship to now include tire delivery and installations.
    EP Energy Corporation (NYSE: EPE) jumped 21.3 percent to $2.68 following Q1 results.
    LendingClub Corporation (NYSE: LC) surged 20.4 percent to $3.395 following better-than-expected Q1 earnings.
    Superior Industries International, Inc. (NYSE: SUP) gained 19 percent to $15.82 after reporting Q1 results.
    Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM) shares rose 18.5 percent to $8.13 following Q1 results.
    Twilio Inc. (NYSE: TWLO) rose 18.3 percent to $52.47 after the company posted strong quarterly results.
    Cerus Corporation (NASDAQ: CERS) shares jumped 18.3 percent to $6.47 following quarterly results.
    IEC Electronics Corp. (NYSE: IEC) shares climbed 17 percent to $4.68 after reporting better-than-expected quarterly earnings.
    New Relic, Inc. (NYSE: NEWR) rose 16.8 percent to $90.10 following Q4 results.
    Gulfport Energy Corporation (NASDAQ: GPOR)
  • [By Ethan Ryder]

    Engineers Gate Manager LP acquired a new position in Liberty Tripadvisor Holdings Inc Series A (NASDAQ:LTRPA) during the second quarter, Holdings Channel reports. The fund acquired 102,003 shares of the technology company’s stock, valued at approximately $1,642,000.

  • [By Lisa Levin]

    Liberty TripAdvisor Holdings, Inc. (NASDAQ: LTRPA) shares shot up 32 percent to $12.175 following TripAdvisor Q1 earnings beat.

    Shares of ZAGG Inc (NASDAQ: ZAGG) got a boost, shooting up 27 percent to $14.60 after the company posted better-than-expected Q1 earnings.

  • [By Lisa Levin]

    Liberty TripAdvisor Holdings, Inc. (NASDAQ: LTRPA) shares shot up 30 percent to $12.05 following TripAdvisor Q1 earnings beat.

    Shares of ZAGG Inc (NASDAQ: ZAGG) got a boost, shooting up 26 percent to $14.48 after the company posted better-than-expected Q1 earnings.

Hot Casino Stocks For 2019: Daktronics, Inc.(DAKT)

Advisors’ Opinion:

  • [By Lisa Levin] Companies Reporting Before The Bell
    Dick's Sporting Goods, Inc. (NYSE: DKS) is projected to report its quarterly earnings at $0.45 per share on revenue of $1.89 billion.
    Columbus McKinnon Corporation (NASDAQ: CMCO) is estimated to report its quarterly earnings at $0.5 per share on revenue of $209.35 million.
    Analog Devices, Inc. (NASDAQ: ADI) is expected to report its quarterly earnings at $1.38 per share on revenue of $1.47 billion.
    Michael Kors Holdings Limited (NYSE: KORS) is projected to report its quarterly earnings at $0.59 per share on revenue of $1.15 billion.
    Movado Group, Inc. (NYSE: MOV) is expected to report its quarterly earnings at $0.11 per share on revenue of $109.47 million.
    Chico's FAS, Inc. (NYSE: CHS) is estimated to report its quarterly earnings at $0.26 per share on revenue of $552.31 million.
    DSW Inc. (NYSE: DSW) is projected to report its quarterly earnings at $0.37 per share on revenue of $681.89 million.
    Daktronics, Inc. (NASDAQ: DAKT) is expected to report its quarterly earnings at $0.05 per share on revenue of $147.20 million.
    Destination XL Group, Inc. (NASDAQ: DXLG) is estimated to report a quarterly loss at $0.14 per share on revenue of $107.63 million.
    Bank of Montreal (NYSE: BMO) is expected to report its quarterly earnings at $1.67 per share on revenue of $4.21 billion.
    MakeMyTrip Limited (NASDAQ: MMYT) is projected to report its quarterly loss at $0.39 per share on revenue of $143.03 million.
    EVINE Live Inc. (NASDAQ: EVLV) is expected to report its quarterly loss at $0.02 per share on revenue of $155.98 million.
    RBC Bearings Incorporated (NASDAQ: ROLL) is estimated to report its quarterly earnings at $1.14 per share on revenue of $175.55 million.

     

  • [By Shane Hupp]

    Media stories about Daktronics (NASDAQ:DAKT) have trended somewhat positive this week, according to Accern Sentiment. Accern identifies negative and positive media coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Daktronics earned a daily sentiment score of 0.11 on Accern’s scale. Accern also gave news articles about the technology company an impact score of 47.3861611544164 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.

  • [By Logan Wallace]

    Daktronics (NASDAQ:DAKT) was upgraded by stock analysts at ValuEngine from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Thursday.

Hot Casino Stocks For 2019: Sarepta Therapeutics, Inc.(SRPT)

Advisors’ Opinion:

  • [By Brian Orelli]

    Today, it was PTC Therapeutics’ turn to take a hit, falling 30.6% today, after competitor Sarepta Therapeutics (NASDAQ:SRPT) presented data for its gene therapy to treat Duchenne muscular dystrophy (DMD).

  • [By Logan Wallace]

    Barclays upgraded shares of Sarepta Therapeutics (NASDAQ:SRPT) from an equal weight rating to an overweight rating in a research report released on Friday morning, MarketBeat.com reports. They currently have $107.00 target price on the biotechnology company’s stock, up from their prior target price of $55.00.

  • [By Max Byerly]

    Colony Group LLC purchased a new stake in shares of Sarepta Therapeutics Inc (NASDAQ:SRPT) during the 2nd quarter, HoldingsChannel.com reports. The fund purchased 1,746 shares of the biotechnology company’s stock, valued at approximately $231,000.

  • [By WWW.GURUFOCUS.COM]

    For the details of ETF Portfolio Partners, Inc.’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=ETF+Portfolio+Partners%2C+Inc.

    These are the top 5 holdings of ETF Portfolio Partners, Inc.Vanguard Total Stock Market (VTI) – 194,472 shares, 17.91% of the total portfolio. Shares added by 1.13%iShares Core U.S. Aggregate Bond (AGG) – 254,189 shares, 17.72% of the total portfolio. Shares added by 3.15%iShares Russell 1000 (IWB) – 98,181 shares, 9.78% of the total portfolio. Shares added by 0.56%Vanguard FTSE Developed Markets (VEA) – 322,914 shares, 9.08% of the total portfolio. Shares added by 1.20%iShares S&P 500 Value (IVE) – 108,531

  • [By Chris Lange]

    Sarepta Therapeutics Inc. (NASDAQ: SRPT) is one of the top biotechs in Janney’s coverage universe, and it has been actively building the company’s gene therapy portfolio, beginning from neuromuscular diseases but now extending to lysosomal storage disorders and central nervous system indications. The initial data from the Limb-Girdle Muscular Dystrophy type 2E study to be announced on Wednesday morning, if positive, will represent another big step forward for Sarepta. The fact that this data will be reported separately from the quarterly financial results on the same day suggests its importance.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Sarepta Therapeutics (SRPT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot Casino Stocks For 2019: Veeva Systems Inc.(VEEV)

Advisors’ Opinion:

  • [By ]

    It provides cloud-based software to healthcare companies. And it has a track record of strong revenue and earnings growth. Which company is it? Veeva Systems (NYSE:VEEV) is a correct answer. So is athenahealth (NASDAQ:ATHN).  

  • [By Motley Fool Transcribing]

    Veeva Systems (NYSE:VEEV) Q4 2019 Earnings Conference CallFeb. 26, 2019 4:30 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Shane Hupp]

    Veeva Systems Inc (NYSE:VEEV) insider Eleni Nitsa Zuppas sold 7,200 shares of the stock in a transaction dated Tuesday, September 11th. The stock was sold at an average price of $103.30, for a total transaction of $743,760.00. Following the sale, the insider now owns 12,398 shares of the company’s stock, valued at approximately $1,280,713.40. The sale was disclosed in a document filed with the SEC, which can be accessed through this link.

  • [By Beth McKenna]

    Shares of Veeva Systems (NYSE:VEEV) rocketed 38% in August, according to data from S&P Global Market Intelligence. This brings the life sciences industry-focused, cloud-based software solutions provider’s year-to-date 2018 return to 82.7% through Wednesday, Sept. 5.

  • [By Leo Sun, John Bromels, and Dan Caplinger]

    It might seem tough to find high-growth stocks in an aging bull market. However, there are still attractive stocks in the cloud, online travel, and business services industries. Today, three of our Motley Fool contributors will share their favorite high-growth plays in those markets: Veeva Systems (NYSE:VEEV), Booking Holdings (NASDAQ:BKNG), and Cintas (NASDAQ:CTAS).

Top Blue Chip Stocks To Buy Right Now

U.K. stocks on Wednesday wavered, with the International Monetary Fund set to offer its assessment of the British economy, but blue chips remained close to a six-week high.

London-listed shares were lower alongside other global markets, which were unable to gain much traction after U.S. lawmakers made a major push forward into overhauling the country’s tax code.

How markets are moving: The FTSE 100 index
UKX, -0.13%
was up 1 point at 7,545.46 after dipping into negative territory. The basic materials and health care groups were gaining the most, but consumer goods and utilities were among the sector that fell. On Tuesday, the index rose 0.1% and marked it best close since Nov. 6.

Top Blue Chip Stocks To Buy Right Now: Arrow Electronics, Inc.(ARW)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Arrow Electronics (ARW)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Motley Fool Transcribing]

    Arrow Electronics (NYSE:ARW) Q4 2018 Earnings Conference CallFeb. 7, 2019 1:00 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Lee Jackson]

    This award-winning company looks poised to come in strong for the quarter. Arrow Electronics Inc. (NYSE: ARW) is a worldwide provider of products, services and solutions to industrial and commercial users of electronic components and enterprise computing solutions.

  • [By Ethan Ryder]

    PNC Financial Services Group Inc. increased its holdings in Arrow Electronics, Inc. (NYSE:ARW) by 29.7% in the first quarter, HoldingsChannel.com reports. The firm owned 19,225 shares of the technology company’s stock after buying an additional 4,405 shares during the quarter. PNC Financial Services Group Inc.’s holdings in Arrow Electronics were worth $1,480,000 at the end of the most recent reporting period.

Top Blue Chip Stocks To Buy Right Now: Kitov Pharamceuticals Holdings Ltd.(KTOV)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    TransEnterix, Inc. (NYSE: TRXC) rose 28.8 percent to $4.03 in pre-market trading after the company disclosed that it has received the FDA clearance for expanded indications for its Senhance Surgical System.
    Global Eagle Entertainment Inc. (NASDAQ: ENT) rose 15.6 percent to $2.30 in pre-market trading.
    Companhia Brasileira de Distribuição (NYSE: CBD) rose 13.2 percent to $24.20 in pre-market trading.
    ZTO Express (Cayman) Inc. (NYSE: ZTO) rose 12.2 percent to $21.65 in pre-market trading. Alibaba and Cainiao agreed to make strategic investment in ZTO Express of $1.38 billion.
    DHI Group, Inc. (NYSE: DHX) rose 10.8 percent to $2.05 in pre-market trading.
    Momo Inc. (NASDAQ: MOMO) shares rose 9.6 percent to $42.68 in pre-market trading after the company reported better-than-expected results for its first quarter and issued strong sales forecast for the second quarter.
    Xenon Pharmaceuticals Inc. (NASDAQ: XENE) shares rose 9.1 percent to $6.00 in pre-market trading.
    Universal Display Corporation (NASDAQ: OLED) rose 8.4 percent to $108.00 in pre-market trading.
    Jupai Holdings Limited (NYSE: JP) shares rose 7 percent to $24.50 in pre-market trading after reporting Q1 results.
    Net 1 UEPS Technologies, Inc. (NASDAQ: UEPS) rose 5.9 percent to $10.61 in pre-market trading.
    Frontline Ltd. (NYSE: FRO) rose 5.9 percent to $5.04 in pre-market trading.
    Evogene Ltd. (NASDAQ: EVGN) rose 5.5 percent to $3.27 in pre-market trading after reporting Q1 results.
    Sears Holdings Corporation (NASDAQ: SHLD) rose 5.5 percent to $3.68 in pre-market trading after gaining 5.44 percent on Friday.
    Kitov Pharma Ltd (NASDAQ: KTOV) shares rose 5.4 percent to $2.16 in pre-market trading.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Lisa Levin]

    Kitov Pharma Ltd (NASDAQ: KTOV) shares dropped 17 percent to $2.53. Kitov Pharma priced its 3.26 million ADS offering at $2.50 per ADS.

    Shares of Ambow Education Holding Ltd. (NASDAQ: AMBO) were down 26 percent to $4.1999.

  • [By Lisa Levin]

    Kitov Pharma Ltd (NASDAQ: KTOV) shares dropped 16 percent to $2.56. Kitov Pharma priced its 3.26 million ADS offering at $2.50 per ADS.

    Shares of Ambow Education Holding Ltd. (NASDAQ: GLNG) were down 28 percent to $4.10.

Top Blue Chip Stocks To Buy Right Now: Brink's Company (BCO)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares surged 144.96 percent to close at $265.61 on Thursday in reaction to an encouraging Phase 2 clinical trial update. The clinical-stage biopharmaceutical company said its liver-directed, thyroid hormone receptor called MGL-3196 showed a statistical significance in the primary endpoint of lowering liver fat at 12 weeks and also 36 weeks.
    Viking Therapeutics, Inc. (NASDAQ: VKTX) shares rose 101.01 percent to close at $9.99 on Thursday after falling 4.42 percent on Wednesday.
    Akers Biosciences, Inc. (NASDAQ: AKER) jumped 45.58 percent to close at $0.474. The developer of rapid health information technologies said Wednesday afternoon it was granted a 180-day extension from the Nasdaq Stock Market to meet the requirement of a minimum $1.00 per share closing bid price for 10 straight days.
    Kitov Pharma Ltd (NASDAQ: KTOV) gained 40.93 percent to close at $3.03 after the FDA approved Kitov's Consensi for the treatment of osteoarthritis pain and hypertension.
    China Customer Relations Centers, Inc. (NASDAQ: CCRC) rose 28.21 percent to close at $19.86.
    J.Jill, Inc. (NYSE: JILL) climbed 26.45 percent to close at $7.84 after the company posted upbeat quarterly earnings.
    Curis, Inc. (NASDAQ: CRIS) shares climbed 21.93 percent to close at $2.78 in reaction to an encouraging FDA update. The biotechnology company that focuses on therapies for the treatment of cancer said the FDA granted a Fast Track designation for fimepinostat (CUDC-907) in patients with relapsed or refractory.
    Boxlight Corporation (NASDAQ: BOXL) gained 21.23 percent to close at $7.48.
    Kirkland's, Inc. (NASDAQ: KIRK) rose 16.21 percent to close at $12.83 after reporting upbeat Q1 results.
    The Brink's Company (NYSE: BCO) jumped 16.2 percent to close at $79.25 as the company announced plans to acquire Dunbar Armored for $520 million in cash.
    Applied Optoelectronics, Inc. (NASDAQ: AAOI) rose 15.14 percent to c
  • [By Max Byerly]

    Shares of Brink’s (NYSE:BCO) have earned a consensus rating of “Buy” from the nine research firms that are currently covering the stock, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, one has given a hold recommendation and six have issued a buy recommendation on the company. The average 1-year price objective among brokerages that have updated their coverage on the stock in the last year is $99.50.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Brink’s (BCO)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top Blue Chip Stocks To Buy Right Now: Sarepta Therapeutics, Inc.(SRPT)

Advisors’ Opinion:

  • [By Jim Crumly]

    As for individual stocks, Boeing (NYSE:BA) slumped due to trade concerns, and Sarepta Therapeutics (NASDAQ:SRPT) soared following positive trial results.

  • [By Todd Campbell]

    Investors cheered news that PTC Therapeutics’ (NASDAQ:PTCT) clinical-stage drug for spinal muscular atrophy (SMA) is delivering impressive early-stage efficacy. However, those cheers turned to jeers after competitor Sarepta Therapeutics (NASDAQ:SRPT) reported promising data for its Duchenne muscular dystrophy (DMD) gene therapy. Could Sarepta Therapeutics’ next-generation DMD treatment derail sales of PTC Therapeutics’ existing DMD drugs? And how excited should investors be about PTC Therapeutics’ opportunity to reshape SMA treatment anyway?

  • [By Keith Speights]

    Three biotech stocks — Solid Biosciences (NASDAQ:SLDB), Sarepta Therapeutics (NASDAQ:SRPT), and Heron Therapeutics (NASDAQ:HRTX) — soared this week by 30% or more thanks to news that brought smiles to investors’ faces. Here’s what drove these stocks higher and whether or not they’re smart picks to buy now.

  • [By Keith Speights]

    Three gene therapy stocks aren’t just hot in 2018 — they’re red-hot. Shares of  Sarepta Therapeutics (NASDAQ:SRPT), Solid Biosciences (NASDAQ:SLDB), and uniQure (NASDAQ:QURE) have nearly doubled or generated even greater gains so far this year. But is it too late for investors to buy these gene therapy stocks? Here’s what you need to know.

  • [By Max Byerly]

    Royal Bank of Canada restated their outperform rating on shares of Sarepta Therapeutics (NASDAQ:SRPT) in a research report report published on Wednesday morning, MarketBeat reports. The firm currently has a $200.00 target price on the biotechnology company’s stock, up from their previous target price of $187.00.

Top Casino Stocks To Buy Right Now

Wynn Resorts (WYNN) soared nearly to the top of the S&P 500 today after Morgan Stanley argued that the casino stock had the potential to double.

Agence France-Presse/Getty Images

Wynn Resortsgained 4.8% to $104.30 today, while the S&P 500 finished little changed at2,373.47. At 2:45, Wynn was easily the top performing stock in the S&P 500, only to be surpassed by Citrix’s (CTXS) late day surge.

Morgan Stanley’s Thomas Allen and team explain how Wynn could double:

Our AlphaWise work on Google search data and separate analyses of market trends suggest the Street is too low on WYNN’s Macau market share gains. Our base case implies 20% upside; bull case, the stock could double.

Consensus forecasts WYNN to essentially not grow Macau market share over 4Q16, despite the Aug ’16 opening of Wynn Palace (which increased WYNN’s room capacity by 170%) and the general view that the benefit from the property has been disappointing so far. We see upside to WYNN’s market share supported by (1) analysis of Google search trends, (2) current market dynamics and WYNN actions, and (3) the performance of WYNNs first Macau property

Top Casino Stocks To Buy Right Now: Sarepta Therapeutics, Inc.(SRPT)

Advisors’ Opinion:

  • [By Keith Speights]

    Three biotech stocks — Solid Biosciences (NASDAQ:SLDB), Sarepta Therapeutics (NASDAQ:SRPT), and Heron Therapeutics (NASDAQ:HRTX) — soared this week by 30% or more thanks to news that brought smiles to investors’ faces. Here’s what drove these stocks higher and whether or not they’resmart picks to buy now.

  • [By Brian Orelli]

    Today, it was PTC Therapeutics’ turn to take a hit, falling 30.6% today, after competitor Sarepta Therapeutics (NASDAQ:SRPT) presented data for its gene therapy to treat Duchenne muscular dystrophy (DMD).

  • [By Motley Fool Staff]

    Last week, Sarepta Therapeutics (NASDAQ:SRPT) unveiled early stage data from trials evaluating a gene therapy for Duchenne muscular dystrophy, and the results were really impressive. Based on increases in micro-dystrophin production and decreases in markers of muscle damage, the company’s plan to insert a gene in patients that produces dystrophin may help over half of those diagnosed with this devastating disease.

  • [By WWW.GURUFOCUS.COM]

    For the details of ETF Portfolio Partners, Inc.’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=ETF+Portfolio+Partners%2C+Inc.

    These are the top 5 holdings of ETF Portfolio Partners, Inc.Vanguard Total Stock Market (VTI) – 194,472 shares, 17.91% of the total portfolio. Shares added by 1.13%iShares Core U.S. Aggregate Bond (AGG) – 254,189 shares, 17.72% of the total portfolio. Shares added by 3.15%iShares Russell 1000 (IWB) – 98,181 shares, 9.78% of the total portfolio. Shares added by 0.56%Vanguard FTSE Developed Markets (VEA) – 322,914 shares, 9.08% of the total portfolio. Shares added by 1.20%iShares S&P 500 Value (IVE) – 108,531

Top Casino Stocks To Buy Right Now: Progenics Pharmaceuticals Inc.(PGNX)

Advisors’ Opinion:

  • [By Cory Renauer]

    Here’s what you need to know about the catalysts that could send these stocks soaring, or plummeting, in the third quarter.

    Company Market Cap Incoming Catalyst
    Spark Therapeutics Inc. (NASDAQ:ONCE) $3.09 billion Clinical trial results
    Zogenix, Inc. (NASDAQ:ZGNX) $1.56 billion Clinical trial results
    Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) $593 million PDUFA date

    Data source: Yahoo! Finance.

  • [By Keith Speights]

    Neurocrine Biosciences (NASDAQ:NBIX), along with partner AbbVie (NYSE:ABBV), Progenics Pharmaceuticals (NASDAQ:PGNX), and Insys Pharmaceuticals (NASDAQ:INSY) await major approval decisions by the U.S. Food and Drug Administration (FDA). Here’s what you need to know about the potential catalysts for these biotech stocks.

  • [By Chris Lange]

    Progenics Pharmaceuticals Inc. (NASDAQ: PGNX) has a PDUFA date set for July 30 for its malignant pheochromocytoma and paraganglioma treatment, Azedra.

Top Casino Stocks To Buy Right Now: Newfield Exploration Company(NFX)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Fernwood Investment Management LLC trimmed its stake in Newfield Exploration (NYSE:NFX) by 6.0% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 31,500 shares of the energy company’s stock after selling 2,000 shares during the quarter. Fernwood Investment Management LLC’s holdings in Newfield Exploration were worth $769,000 at the end of the most recent quarter.

  • [By Ethan Ryder]

    Earnest Partners LLC raised its position in Newfield Exploration Co. (NYSE:NFX) by 11.4% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,084,526 shares of the energy company’s stock after purchasing an additional 110,630 shares during the period. Earnest Partners LLC owned 0.54% of Newfield Exploration worth $26,484,000 at the end of the most recent reporting period.

  • [By Matthew DiLallo]

    Oil prices have continued rebounding this year, with the U.S. benchmark price WTI up another 7% to around $65 per barrel. That improving oil price has helped drive up most oil stocks. I say most because Devon Energy (NYSE:DVN), Apache (NYSE:APA), and Newfield Exploration (NYSE:NFX) are flat to down so far this year because investors seem to have overlooked them entirely. Because of that, they trade for a dirt-cheap valuation versus their peers, making them intriguing options to consider.

  • [By Matthew DiLallo]

    The IEA’s forecast bodes well for oil stocks, especially those that have underperformed during the rally over the past year. Two that stand out are Newfield Exploration (NYSE:NFX) and Apache (NYSE:APA), since both have lost value even though oil has been red-hot. Because of that, they trade at dirt cheap valuations versus their peers. That underperformance doesn’t make sense given the growth these companies can deliver at much lower oil prices.

Top Casino Stocks To Buy Right Now: Continental Resources, Inc.(CLR)

Advisors’ Opinion:

  • [By Logan Wallace]

    Clearwater Seafoods (TSE:CLR) Director Richard Lawrence Gillis Hood sold 6,200 shares of the firm’s stock in a transaction that occurred on Monday, May 14th. The shares were sold at an average price of C$4.90, for a total value of C$30,380.00.

  • [By Jason Hall]

    Since oil prices peaked in 2014, both Total and Shell have managed to generate positive total returns for investors who held through the downturn, in large part because of their diverse operations. Neither has come close to outperforming theS&P 500, but it could have been far worse; one only has to look at some of the biggest independent oil producers, includingApache Corporation(NYSE:APA) (down 53%),Anadarko Petroleum Corporation(NYSE:APC) (down 33%), andContinental Resources, Inc.(NYSE:CLR) (down 12.3%) to appreciate the benefit of Total’s and Shell’s more diversified operations.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Continental Resources (CLR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Continental Resources (NYSE:CLR) was downgraded by analysts at ValuEngine from a “buy” rating to a “hold” rating in a report released on Monday.

  • [By Joseph Griffin]

    These are some of the media stories that may have effected Accern’s analysis:

    Get Continental Resources alerts:

    Irans Oil Production and Exports Could Help Crude Oil Bulls (finance.yahoo.com) The Cash Flow King (investingdaily.com) Continental Resources Can Soar Without Bottlenecks (seekingalpha.com) Are Options Traders Betting on a Big Move in Continental Resources (CLR) Stock? (zacks.com) Why Aren’t Permian Oil Producers Profitable? (oilprice.com)

    Shares of NYSE CLR traded down $0.40 during mid-day trading on Tuesday, hitting $64.21. The company’s stock had a trading volume of 2,923,330 shares, compared to its average volume of 2,421,609. The firm has a market capitalization of $25.63 billion, a PE ratio of 125.90 and a beta of 1.27. The company has a current ratio of 0.93, a quick ratio of 0.85 and a debt-to-equity ratio of 1.15. Continental Resources has a one year low of $29.08 and a one year high of $69.91.

Top 5 Undervalued Stocks To Buy For 2019

Gilead Sciences (GILD) is a large capitalization pharmaceutical and biotechnology company best known for its HIV and HCV (hepatitis C) therapies.

After Gilead showed it could generate large amounts of revenue from new, highly effective cures for HCV, its stock price rose to a peak of $123.57 per share in June 2015. That was quite a climb upward from $37.16 per share at the beginning of 2013, but since then the stock price, although volatile, has drifted mainly downward.

Harvoni pill. Source: Gilead.com

Many analysts and financial journalists, including this author, believe that Gilead is undervalued. Yet despite that, good news has not lifted the price of the stock for long in 2016 or 2017. After briefly reviewing the causes of the low stock valuation, I will cover three future catalysts that should boost the stock price. But my current thesis is that the stock price is governed by psychology, not fundamentals. I do not pretend to know for certain what change in investor psychology might bring Gilead up to fair valuation.

Top 5 Undervalued Stocks To Buy For 2019: Information Services Group Inc.(III)

Advisors’ Opinion:

  • [By Joseph Griffin]

    RMR Group (NASDAQ: RMR) and Information Services Group (NASDAQ:III) are both finance companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, risk, profitability, dividends, valuation, institutional ownership and earnings.

  • [By Logan Wallace]

    CGI Group (NYSE: GIB) and Information Services Group (NASDAQ:III) are both computer and technology companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, earnings, dividends, analyst recommendations, risk, valuation and institutional ownership.

  • [By Joseph Griffin]

    3i Group (LON:III) had its price target upped by Societe Generale from GBX 1,020 ($13.58) to GBX 1,130 ($15.04) in a research note released on Thursday. The brokerage currently has a buy rating on the stock.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Information Services Group, Inc. Common Stock (III)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Undervalued Stocks To Buy For 2019: Smart(SFS)

Advisors’ Opinion:

  • [By Joseph Griffin]

    ValuEngine lowered shares of Smart & Final Stores (NYSE:SFS) from a sell rating to a strong sell rating in a research report released on Wednesday.

  • [By Lisa Levin]

     

    Losers
    Heat Biologics, Inc. (NASDAQ: HTBX) shares tumbled 48.59 percent to close at $1.275 on Thursday after the company priced its $18,000,000 public offering.
    InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) fell 38.77 percent to close at $8.26 on Thursday.
    Check-Cap Ltd. (NASDAQ: CHEK) shares tumbled 27.43 percent to close at $8.81.
    Achaogen, Inc. (NASDAQ: AKAO) dropped 24.76 percent to close at $11.06 in reaction to a disappointing update from an FDA AdCom panel. The FDA panel voted favorably for the company's Plazcomicin for treatment of adults with complicated urinary tract infections, but also voted against the therapy to be used as a treatment for bloodstream infections.
    Anika Therapeutics, Inc. (NASDAQ: ANIK) shares declined 24.68 percent to close at $34.80 after the company posted downbeat quarterly results.
    LSC Communications, Inc. (NASDAQ: LKSD) shares fell 24.22 percent to close at $12.64 following wider-than-expected Q1 loss.
    Cardinal Health, Inc. (NYSE: CAH) fell 21.42 percent to close at $50.80 following downbeat quarterly profit.
    Horizon Global Corporation (NYSE: HZN) dropped 20.42 percent to close at $6.00 following downbeat quarterly earnings.
    Hornbeck Offshore Services, Inc. (NYSE: HOS) slipped 20.11 percent to close at $2.90 following wider-than-expected Q1 loss.
    Esperion Therapeutics, Inc. (NASDAQ: ESPR) fell 19.28 percent to close at $36.93. Esperion Therapeutics stock lost roughly a third of its value Wednesday after the company reported mixed Phase III results for its leading drug candidate, bempedoic acid. JP Morgan downgraded Esperion Therapeutics from Neutral to Underweight.
    Laredo Petroleum, Inc. (NYSE: LPI) declined 17.77 percent to close at $8.98 after the company reported weaker-than-expected Q1 earnings.
    The Habit Restaurants, Inc. (NASDAQ: HABT) dipped 16.1 percent to close at $8.60 after the company reported downbeat quarterly results.
    Arcadia Biosciences, Inc. (N

  • [By Brian Stoffel]

    But over the past five years, the industry has been turned upside down by changes in business models, a focus on delivery, and mass consolidation. While the dust is far from settled, here are 10 of the largest publicly traded grocers you can buy stock in.

    Company Market Cap Stores Regions Chains
    Amazon (NASDAQ:AMZN) $780 billion 500 USA Whole Foods
    Walmart (NYSE:WMT) $250 billion 11,700 Worldwide Walmart
    Costco (NASDAQ:COST) $86 billion 750 USA Costco
    Kroger (NYSE:KR) $21 billion 2,800 USA Kroger, Roundy’s, Ralph’s, Food 4 Less
    Sprouts (NASDAQ: SFM) $3 billion 300 Western and Southern U.S. Sprouts Farmer’s Market
    Weis Market (NYSE: WMK) $1.3 billion 200 Mid-Atlantic U.S. Weis Market
    SUPERVALU(NYSE: SVU) $630 million 100 Midwestern U.S. Cub Foods, Shopper’s Food, Hornbacher
    Ingles Market(NASDAQ: IMKTA) $580 million 200 Southeastern U.S. Ingles Market, Sav-Mor
    Smart & Final(NYSE: SFS) $360 million 350 Western U.S. Smart & Final, Cash & Carry
    Natural Grocers (NYSE: NGVC) $230 million 150 Western U.S. Natural Grocers

    Data source: Yahoo! Finance, company websites.

  • [By Shane Hupp]

    Smart & Final (NYSE: SFS) and Kroger (NYSE:KR) are both consumer staples companies, but which is the better business? We will compare the two companies based on the strength of their dividends, institutional ownership, profitability, earnings, analyst recommendations, valuation and risk.

Top 5 Undervalued Stocks To Buy For 2019: International Speedway Corporation(ISCA)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on International Speedway Corp Class A (ISCA)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on International Speedway Corp Class A (ISCA)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Motley Fool Staff]

    International Speedway Corporation (NASDAQ: ISCA)Q2 2018 Earnings Conference callJul. 05, 2018, 1:00 pm ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

Top 5 Undervalued Stocks To Buy For 2019: Coca-Cola Bottling Co. Consolidated(COKE)

Advisors’ Opinion:

  • [By Logan Wallace]

    Coca-Cola Bottling Co. Consolidated (NASDAQ: COKE) and Coca Cola Femsa (NYSE:KOF) are both consumer staples companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, dividends, profitability, institutional ownership, analyst recommendations, risk and valuation.

  • [By Ethan Ryder]

    Coca-Cola Bottling Co. Consolidated (NASDAQ:COKE) released its quarterly earnings data on Tuesday. The company reported ($0.85) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.88 by ($1.73), reports. Coca-Cola Bottling Co. Consolidated had a return on equity of 11.63% and a net margin of 2.23%.

Top 5 Undervalued Stocks To Buy For 2019: Sarepta Therapeutics, Inc.(SRPT)

Advisors’ Opinion:

  • [By Dan Caplinger]

    That only makes it more important to be selective about the stocks you choose to own. Even under more difficult market conditions, some stocks have continued to push sharply higher. HollyFrontier (NYSE:HFC), Boot Barn Holdings (NYSE:BOOT), and Sarepta Therapeutics (NASDAQ:SRPT) have each tripled since this time last year, and bullish shareholders think that there could be further gains in store for the three companies if some key things keep going right.

  • [By Keith Speights]

    Three gene therapy stocks aren’t just hotin 2018 — they’re red-hot. Shares ofSarepta Therapeutics (NASDAQ:SRPT), Solid Biosciences (NASDAQ:SLDB), and uniQure(NASDAQ:QURE)have nearly doubled or generated even greater gains so far this year. But is it too late for investors to buy these gene therapy stocks? Here’s what you need to know.

  • [By Keith Speights]

    But some stocks don’t take nearly that long to double. Three stocks in particularhave doubled investors’ money — and more — in just the last 12 months. Here’s why Nektar Therapeutics (NASDAQ:NKTR), CRISPR Therapeutics (NASDAQ:CRSP), and Sarepta Therapeutics (NASDAQ:SRPT) became such huge winners — and whether or not their impressive momentum can continue.

Top 10 Value Stocks To Invest In Right Now

Whole Foods Market (NASDAQ:WFM) has had a bad time on the market over the past couple of months, losing over 16% of its value on the back of a weak financial performance in its last reported quarter. But, in my opinion, the recent drop in Whole Foods’ shares is an opportunity to buy more of the stock since there are tangible improvements being witnessed across Whole Foods’ operations as discussed in this article. Let’s take a look.

Sales building initiatives are delivering results

Whole Foods Market’s focus on improving its sales is delivering results, slowly but steadily. For instance, its comparable store sales dropped 2.6% last quarter as compared to a decline of 3% in the preceding quarter. More importantly, Whole Foods is witnessing an improvement in its comparable store sales this quarter as well, as the rate of decline of its comp sales has gone down to 2.4% in the first three weeks of the 12-week fourth quarter.

In addition, the company expects square footage growth of 7% in 2016 and approximately 6% in 2017, driven by the addition of new stores to its portfolio that continue to witness positive comp sales growth. For instance, last quarter, Whole Foods opened 12 new stores that include its first 365 Store. The company has opened one 365 and two Whole Foods Market stores in the ongoing quarter, and it plans to open two additional stores, including one 365 and two Whole Foods Market stores.

Top 10 Value Stocks To Invest In Right Now: CBOE Holdings Inc.(CBOE)

Advisors’ Opinion:

  • [By Dustin Blitchok]

    After CBOE Global Markets Inc (NASDAQ: CBOE) launched bitcoin futures in December, Charles Schwab Corporation (NYSE: SCHW) didn't immediately make the product available to clients, said Barry Metzger, the brokerage’s senior vice president of global, trading and advice.

  • [By Max Byerly]

    Deutsche B枚rse (OTCMKTS: DBOEY) and Cboe Global Markets (NASDAQ:CBOE) are both large-cap finance companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, risk, dividends, institutional ownership, profitability, valuation and analyst recommendations.

  • [By Dan Caplinger]

    Last December, two major futures exchanges started offering futures contracts on bitcoin. CBOE Global Markets (NASDAQ:CBOE) was the first to market with its futures offering, and CME Group (NASDAQ:CME) didn’t waste any time coming out with its own version of a bitcoin contract.

  • [By Asit Sharma]

    Cboe Global Markets, Inc. (NASDAQ:CBOE) reported expansive earnings growth in its first-quarter 2018 report, issued on May 3. In addition to revenue tacked on from its acquisition of Bats Global Markets in March 2017, Cboe enjoyed increased volume in trading of the company’s proprietary VIX (Cboe Volatility Index) futures and options.

  • [By Sean Williams]

    But times have changed, the virtual-currency market has matured a bit, and institutional investors have had a means to bet on the crypto market in a more traditional sense over the past couple of months. By this, I mean that both the CME Groupand CBOE Global Markets (NASDAQ:CBOE) have offered bitcoin futures on their trading platforms since December, providing a more traditional avenue for Wall Street to place its bets.

Top 10 Value Stocks To Invest In Right Now: Prudential Public Limited Company(PUK)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Here are some of the news headlines that may have effected Accern’s rankings:

    Get Prudential alerts:

    Zacks Investment Research Lowers Prudential (PUK) to Hold (americanbankingnews.com) Financial wellness program popularity rises among employers, up 63 percentage points in two years (markets.financialcontent.com) FY2018 EPS Estimates for Prudential (PUK) Reduced by Jefferies Group (americanbankingnews.com) Jefferies Group Weighs in on Prudential’s FY2020 Earnings (PUK) (americanbankingnews.com) ValuEngine Downgrades Prudential (PUK) to Hold (americanbankingnews.com)

    Shares of PUK stock traded down $0.02 during trading on Tuesday, hitting $51.56. 141,455 shares of the stock traded hands, compared to its average volume of 198,097. The firm has a market cap of $66.49 billion, a PE ratio of 13.79, a PEG ratio of 1.34 and a beta of 1.55. The company has a debt-to-equity ratio of 0.39, a quick ratio of 0.03 and a current ratio of 0.03. Prudential has a 52-week low of $44.49 and a 52-week high of $55.36.

  • [By Ethan Ryder]

    ValuEngine lowered shares of Prudential (NYSE:PUK) from a buy rating to a hold rating in a research note issued to investors on Wednesday morning.

    Several other analysts have also recently issued reports on the stock. Zacks Investment Research upgraded shares of Prudential from a hold rating to a buy rating and set a $57.00 target price on the stock in a research note on Tuesday, March 27th. Berenberg Bank cut shares of Prudential from a hold rating to a sell rating in a research note on Thursday, March 29th. Finally, Citigroup cut shares of Prudential from a buy rating to a neutral rating in a research note on Wednesday, April 25th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and two have given a buy rating to the company. The stock currently has an average rating of Hold and an average price target of $57.00.

  • [By Ethan Ryder]

    Prudential (NYSE: PUK) and Reinsurance Group of America (NYSE:RGA) are both finance companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, valuation, dividends, risk, profitability and institutional ownership.

Top 10 Value Stocks To Invest In Right Now: Aspen Insurance Holdings Limited(AHL)

Advisors’ Opinion:

  • [By Ethan Ryder]

    The Travelers Companies (NYSE: TRV) and Aspen Insurance (NYSE:AHL) are both finance companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, dividends, profitability, analyst recommendations, valuation, earnings and risk.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Aspen Insurance (AHL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Value Stocks To Invest In Right Now: Lifetime Brands Inc.(LCUT)

Advisors’ Opinion:

  • [By Logan Wallace]

    Stanley Black & Decker (NYSE: SWK) and Lifetime Brands (NASDAQ:LCUT) are both industrial products companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, dividends, valuation, analyst recommendations, profitability, earnings and risk.

Top 10 Value Stocks To Invest In Right Now: Sarepta Therapeutics, Inc.(SRPT)

Advisors’ Opinion:

  • [By Max Byerly]

    Sarepta Therapeutics (NASDAQ:SRPT) had its target price increased by Morgan Stanley from $87.00 to $91.00 in a report issued on Friday. Morgan Stanley currently has an equal weight rating on the biotechnology company’s stock.

  • [By Keith Speights]

    But some stocks don’t take nearly that long to double. Three stocks in particularhave doubled investors’ money — and more — in just the last 12 months. Here’s why Nektar Therapeutics (NASDAQ:NKTR), CRISPR Therapeutics (NASDAQ:CRSP), and Sarepta Therapeutics (NASDAQ:SRPT) became such huge winners — and whether or not their impressive momentum can continue.

  • [By Brian Feroldi]

    After reporting first-quarter results, shares of Sarepta Therapeutics(NASDAQ:SRPT), acommercial-stage biotech focused on rare diseases, jumped 14% as of 3:40 p.m. EDT Friday.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Sarepta Therapeutics (SRPT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Barclays upgraded shares of Sarepta Therapeutics (NASDAQ:SRPT) from an equal weight rating to an overweight rating in a research report released on Friday morning, MarketBeat.com reports. They currently have $107.00 target price on the biotechnology company’s stock, up from their prior target price of $55.00.

  • [By Stephan Byrd]

    Trexquant Investment LP acquired a new position in Sarepta Therapeutics (NASDAQ:SRPT) in the first quarter, Holdings Channel reports. The institutional investor acquired 7,135 shares of the biotechnology company’s stock, valued at approximately $529,000.

Top 10 Value Stocks To Invest In Right Now: Tarena International, Inc.(TEDU)

Advisors’ Opinion:

  • [By Max Byerly]

    K12 (NYSE: LRN) and Tarena International (NASDAQ:TEDU) are both small-cap consumer discretionary companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, dividends, profitability, analyst recommendations, institutional ownership and risk.

  • [By Ethan Ryder]

    Tarena International (NASDAQ: TEDU) and TAL Education (NYSE:TAL) are both business services companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, earnings, analyst recommendations, valuation, dividends and institutional ownership.

Top 10 Value Stocks To Invest In Right Now: DHX Media Ltd.(DHXM)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Turtle Beach Corporation (NASDAQ: HEAR) surged 87.1 percent to $12.98 after the company reported Q1 results and raised its FY18 outlook.
    ARMO BioSciences, Inc. (NASDAQ: ARMO) shares jumped 66.8 percent to $49.735 after Eli Lilly and Company (NYSE: LLY) announced plans to acquire ARMO BioSciences for $50 per share.
    vTv Therapeutics Inc. (NASDAQ: VTVT) gained 34 percent to $2.2920 following announcement that the company will pre-specify new subgroup with the FDA and report Phase 3 Part B results in June.
    Prestige Brands Holdings, Inc. (NYSE: PBH) climbed 22.3 percent to $34.84 after the company posted upbeat Q4 earnings.
    Depomed, Inc. (NASDAQ: DEPO) shares jumped 22.2 percent to $7.28 following better-than-expected Q1 earnings.
    Everspin Technologies, Inc. (NASDAQ: MRAM) gained 19.8 percent to $8.89 after the company reported strong results for its first quarter.
    Luxfer Holdings PLC (NYSE: LXFR) surged 19.8 percent to $17.10 following Q1 results.
    Clean Energy Fuels Corp. (NASDAQ: CLNE) rose 18.3 percent to $2.26 after French company Total announced plans to acquire 25 percent stake in Clean Energy Fuels for $83.4 million.
    Intelligent Systems Corporation (NYSE: INS) gained 17 percent to $7.116.
    Green Dot Corporation (NYSE: GDOT) surged 15.3 percent to $73.00 after reporting upbeat Q1 earnings.
    The Chefs' Warehouse, Inc. (NASDAQ: CHEF) climbed 15 percent to $28.85. Chefs' Warehouse posted Q1 earnings of $0.03 per share on sales of $318.6 million.
    Westport Fuel Systems Inc. (NASDAQ: WPRT) rose 14.2 percent to $2.9701.
    Wright Medical Group N.V. (NASDAQ: WMGI) jumped 13.8 percent to $23.87 after reporting upbeat quarterly earnings.
    Diplomat Pharmacy, Inc. (NYSE: DPLO) gained 13.4 percent to $22.70. Diplomat named Brian Griffin as Chairman and CEO.
    Carvana Co. (NYSE: CVNA) shares rose 13 percent to $27.97 after reporting upbeat Q1 sales.
    Prothena Corporation plc (NASDAQ: PRTA) gained 12 percent to $15.19
  • [By Anders Bylund]

    Family-friendly media company DHX Media (NASDAQ:DHXM) reported third-quarter earnings early Monday morning. Investors didn’t see much to like in this business update, and the stock closed 19.7% lower at the end of the day.

  • [By Dan Caplinger]

    The stock market had a generally solid performance on Monday, with large-cap indexes posting modest gains even as benchmarks that track the changes of smaller stocks underperformed. The big news of the day came on the trade front, where the White House intervened to reverse previous policy with respect to Chinese smartphone giant ZTE in an apparent effort to gain favor with the world’s most populous nation and second-largest economic power. Investors looked for potential winners from the thawing of relations with China, but not all stocks were able to avoid significant losses. Viacom (NASDAQ:VIAB), Synchronoss Technologies (NASDAQ:SNCR), and DHX Media (NASDAQ:DHXM) were among the worst performers on the day. Here’s why they did so poorly.

Top 10 Value Stocks To Invest In Right Now: BGC Partners, Inc.(BGCP)

Advisors’ Opinion:

  • [By ]

    Cramer was bearish on BGC Partners (BGCP) , Dr Pepper Snapple (DPS) , Sterling Construction Co. Inc.  (STRL) and B&G Foods (BGS) .

    Search Jim Cramer’s “Mad Money” trading recommendations using our exclusive “Mad Money” Stock Screener.

  • [By ]

    BGC Partners (BGCP) : “We’re in a market where Goldman Sachs (GS) got slammed. I’m going with them.”

    Ecolab (ECL) : “That’s a terrific situation that I want you to buy more of if it comes down.”

  • [By Logan Wallace]

    LPL Financial (NASDAQ: LPLA) and BGC Partners (NASDAQ:BGCP) are both mid-cap finance companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, valuation, institutional ownership, risk, earnings, dividends and profitability.

Top 10 Value Stocks To Invest In Right Now: Haverty Furniture Companies, Inc.(HVT)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Havertys (NYSE:HVT) – Stock analysts at KeyCorp dropped their Q2 2018 earnings per share estimates for Havertys in a research report issued on Wednesday, May 2nd. KeyCorp analyst B. Thomas now anticipates that the company will post earnings per share of $0.29 for the quarter, down from their previous forecast of $0.31. KeyCorp also issued estimates for Havertys’ Q3 2018 earnings at $0.39 EPS and Q4 2018 earnings at $0.45 EPS.

Top 10 Value Stocks To Invest In Right Now: CrossAmerica Partners LP(CAPL)

Advisors’ Opinion:

  • [By Joseph Griffin]

    CrossAmerica Partners (NYSE:CAPL) last released its quarterly earnings data on Monday, February 26th. The oil and gas company reported $0.06 EPS for the quarter, hitting the consensus estimate of $0.06. CrossAmerica Partners had a return on equity of 4.73% and a net margin of 0.84%. The company had revenue of $552.66 million during the quarter, compared to the consensus estimate of $572.48 million. sell-side analysts anticipate that CrossAmerica Partners will post 0.24 EPS for the current year.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on CrossAmerica Partners (CAPL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    CrossAmerica Partners (NYSE:CAPL) – Research analysts at Jefferies Group reduced their FY2018 earnings estimates for CrossAmerica Partners in a research note issued to investors on Wednesday, May 9th. Jefferies Group analyst C. Mandeville now forecasts that the oil and gas company will earn $0.24 per share for the year, down from their previous forecast of $0.32. Jefferies Group currently has a “Buy” rating and a $28.00 target price on the stock. Jefferies Group also issued estimates for CrossAmerica Partners’ Q1 2019 earnings at $0.07 EPS, Q2 2019 earnings at $0.13 EPS, Q4 2019 earnings at $0.14 EPS and FY2020 earnings at $0.42 EPS.